Changes for page AbbVie Inc.

Last modified by Md. Touhidul Islam on 2024/02/25 06:44

From version < 1.9 >

edited by Md. Touhidul Islam
on 2024/02/25 06:21

To version < 1.10 >

edited by Md. Touhidul Islam
on 2024/02/25 06:22

< >

Change comment: (Autosaved)

Summary

Page properties

Content

@@ -22,7
+22,7 @@
  = Recent Developments =
--* On February 22, 2024, AbbVie and Tentarix Biotherapeutics partnered for a year to develop conditionally active, multi-specific biologic candidates in oncology and immunology, leveraging Tentarix's Tentacles™ platform.
++* On February 22, 2024, AbbVie and Tentarix Biotherapeutics partnered for a year to develop conditionally active, multi-specific biologic candidates in oncology and immunology, leveraging Tentarix's Tentacles™ platform.{{footnote}}https://www.prnewswire.com/news-releases/abbvie-and-tentarix-announce-collaboration-to-develop-conditionally-active-multi-specific-biologics-for-oncology-and-immunology-302068091.html{{/footnote}}
  {{putFootnotes/}}